July 30, 2026 | Health Outcomes, Impetus Digital, Market Access, Medical Innovation, PSP, Pharma Strategy, Value-based care, beyond the pill, digital health, digital voice, health innovation, health literacy, patient activation, patient engagement, patient support program, patientcentricity, real world data, treatment adherence
True “beyond-the-pill” strategy requires shifting from a prescriptive model to a supportive one—using personalized digital tools and authentic patient voices to drive adherence, improve outcomes, and prove value.

The healthcare ecosystem is undergoing a fundamental, albeit gradual and sometimes painfully slow, transformation, shifting from a volume-based model—where prescription volume is prioritized—to one driven by value-based care. In this beyond-the-pill model, emphasis is placed not only on clinical outcomes, but also on real-world patient experiences. At a time when patients demand greater transparency and control over their health journey, patient engagement is no longer a nice-to-have feature or a regulatory checkmark for Pharma—it is a measurable driver of long-term commercial sustainability.
The efficacy of even the most innovative therapies can be fundamentally eroded by poor adherence, low health literacy, and disconnected care pathways. To overcome these issues, creating an environment where the patient is recognized as an active participant in their care journey, empowered to understand and manage their condition, is critical.
First and foremost, improved patient activation requires shared decision-making (SDM). SDM can be defined as a collaborative process that merges clinical evidence with the patient’s values, preferences, and lifestyle to select the optimal treatment path. For Pharma, this represents a crucial strategic shift: moving away from a prescriptive model (Pharma → Prescriber → Patient) to a supportive model that enhances HCP-patient dialogue.
This supportive approach can take many shapes, but one of the most straightforward involves developing tools and resources that enable open, balanced HCP-patient conversations. There is no limit to what this can look like, but popular examples include interactive symptom trackers, risk/benefit calculators, eDiaries, and easy-to-use digital decision aids that direct patients to pertinent information based on their individual demographic and clinical characteristics or risk factors, along with printed and digital educational materials covering the topics that matter most to patients. By investing in SDM support tools, Pharma can help ensure patients not only start therapy but also align psychologically with it, setting the foundation for long-term adherence and treatment success.
The second key factor is radical personalization. Moving beyond basic patient segmentation, true personalization means addressing the patient’s unique and complex barriers and needs. This includes social determinants of health (SDoH), health literacy gaps, logistical hurdles, and/or underlying emotional states…
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
With over 11 years of experience in virtualizing meetings in the life science industry, Impetus Digital has a wealth of experience and knowledge to share.
Scott Arrol, Chief Executive Officer at New Zealand Health IT, discusses the roles of interoperability, connected health, and digital identity in enabling a healthier population. We also explore how NZHIT and…
Christine Jacob, Founder and Managing Director of Digi-Bridges, talks about the future of mobile and digital health, including exciting technologies such as VR and AR. We also touch on a wide variety…
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual “hackathon,” with spectacular results.
Leo Grady, CEO of Paige.AI uncovers what it has been like being a pioneer in the digital therapeutic space and the many challenges that come with bringing AI technology to market….
In the latest episode of Impetus Digital’s Fireside Chat, I sit down with Ville Leppälä, Vertical Lead, Research and Medical, at Varjo. We discuss the potential applications of virtual reality, augmented…
In this episode of Impetus Digital’s Fireside Chat, I sit down with Brenda McPhail from the Canadian Civil Liberties Association. We talk about a myriad of different subjects related to…
In the latest episode of Impetus Digital’s Fireside Chat, I sit down with Mike Waldron, who is the CEO and Co-Founder of Propel VR. We discuss how virtual reality (VR)…
In this fireside chat, Natalie Yeadon sat down with Jeffrey Ruby, Founder & CEO of Newtopia and discussed how a combination of genetic testing, personality-matched coaching, and smart technology can…
We are getting to the point where we need to start considering the long-term effects on the healthcare system when making decisions.

